49.45
-0.20
(-0.40%)
At close: 2:36:11 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-105,811.00
-93,761.00
-57,317.00
-59,264.00
Investing Cash Flow
-45,206.00
-221,147.00
-648,562.00
-256,722.00
Financing Cash Flow
18,148.00
10,414.00
1,210,228.00
110,091.00
End Cash Position
205,255.00
246,677.00
551,171.00
46,822.00
Capital Expenditure
-7,751.00
-5,884.00
-5,867.00
-2,694.00
Issuance of Capital Stock
22,598.00
13,174.00
1,212,514.00
111,929.00
Free Cash Flow
-113,562.00
-99,645.00
-63,184.00
-61,958.00
12/31/2020 - 6/30/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4178.TWO StemCyte International, Ltd.
35.15
+1.59%
6586.TWO CHO Pharma, Inc.
50.90
+1.19%
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
6610.TWO TWi Biotechnology, Inc.
13.75
+0.73%
6580.TWO TaiRx, Inc.
26.00
+1.96%
4170.TWO VBI
14.10
+0.71%
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
6945.TWO AP Biosciences Inc
50.80
-3.05%
7814.TWO HORIEN
33.00
-4.76%
7808.TWO BIONET TX Corp
46.00
-1.08%